Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 68 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8557833

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted
  2. US 8552067

    Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses therefor

    The Regents of the University of California · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  3. US 8552018

    Substituted tricyclic compounds as protein kinase inhibitors

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  4. US 8551964

    Hsp90 inhibitors with modified toxicity

    The Regents of the University of Colorado · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  5. US 8551997

    Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use

    The Board of Regents of the University of Texas System · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  6. US 8546433

    Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer

    Rigel Pharmaceuticals, Inc. · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  7. US 8546322

    Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof

    The Regents of the University of California · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted
  8. US 8541417

    Poly (ADP-ribose) polymerase (PARP) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  9. US 8541457

    Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  10. US 8541475

    MAO-B inhibitors useful for treating obesity

    Jenrin Discovery, LLC · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  11. US 8541403

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  12. US 8536165

    Azabiphenylaminobenzoic acid derivatives as DHODH inhibitors

    Almirall, S.A. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted
  13. US 8536136

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted
  14. US 8530489

    5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  15. US 8529882

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted
  16. US 8524902

    [1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  17. US 8524720

    Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  18. US 8524906

    Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted
  19. US 8518953

    Aminopyrimidines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  20. US 8518937

    Pyrimidinediamine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  21. US 8519137

    Heteroaryl amides useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  22. US 8518942

    Caspase inhibitors and uses thereof

    The Regents of the University of California · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  23. US 8518938

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted
  24. US 8513244

    Neprilysin inhibitors

    Theravance, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted